Novartis To Buy Chinook Therapeutics In Up To $3.5 Bln Cash Deal
Swiss drug major Novartis AG (NVS) announced Monday its agreement to acquire Seattle, Washington-based Chinook Therapeutics for a total value of up to $3.5 billion. The deal includes $3.2 billion upfront or $40 per share in cash upon closing, plus a contingent value right with a value of up to $0.3 billion or $4 per share. This is payable in […]
Read more